Latest Breaking News On - Olivier calvet - Page 2 : comparemela.com

SCHOTT PHARMA : Gets a Neutral rating from UBS

SCHOTT PHARMA : Gets a Neutral rating from UBS
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Olivier-calvet

Schott Pharma falls sharply - 'High dependence on end markets'

Schott Pharma falls sharply - 'High dependence on end markets'
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Italy
Italian
Gaurav-jain
Schott-pharma
Ed-hall
Olivier-calvet
Barclays

REDCARE PHARMACY : Credit Suisse keeps a Sell rating

Olivier Calvet from Credit Suisse retains his negative opinion on the stock with a Sell rating. The target price is increased from EUR 42 to EUR 52.

Olivier-calvet
Credit-suisse

ZUR ROSE GROUP : Sell rating from Credit Suisse

In a research note published by Olivier Calvet, Credit Suisse advises its customers to Sell the stock. The target price has been revised downwards and is now set at CHF 40 as compared to CHF 45. | March 30, 2023

Olivier-calvet
Credit-suisse
Zur-rose-group-ag-stock-exchange
News
Information
Press-release
N
Research
Vote
Published
Y
Olivier

Mynaric AG (MOYFF) Receives a Buy from Kepler Capital

Mynaric AG (MOYFF) Receives a Buy from Kepler Capital
markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.

Olivier-calvet
Kepler-capital
Research-report
Moderate-buy